|
Secondary prevention
Citations 481-490 of 566 total displayed.
|
Past content
(since Feb 1999):
|
- Current Perspectives
Cardiovascular Risk Assessment Based on US Cohort Studies: Findings From a National Heart, Lung, and Blood Institute Workshop
- Scott M. Grundy, Ralph B. D’Agostino, Sr, Lori Mosca, Gregory L. Burke, Peter W.F. Wilson, Daniel J. Rader, James I. Cleeman, Edward J. Roccella, Jeffrey A. Cutler, and Lawrence M. Friedman
Circulation 2001;104:491-496
[Full text]
- Current Perspectives
Current Concepts of the Pathogenesis of the Acute Coronary Syndromes
- Peter Libby
Circulation 2001;104:365-372
[Full text]
- Correspondence
Niacin After Coronary Bypass Grafting and for Coronary Disease Prevention
- William B. Parsons, Jr., David Waters, and Rabih R. Azar
Circulation 2001;104:e7
[Full text]
- Correspondence
Death Rates Versus Deaths
- Kenneth M. Kessler, David A. Morrow, Elliott M. Antman, James A. de Lemos, Robert P. Giugliano, Carolyn H. McCabe, Eugene Braunwald, Sabina A. Murphy, Andrew Charlesworth, and Richard Cairns
Circulation 2001;104:e8
[Full text]
- Clinical Investigations and Reports
Aspirin, Warfarin, or the Combination for Secondary Prevention of Coronary Events in Patients With Acute Coronary Syndromes and Prior Coronary Artery Bypass Surgery
- Thao Huynh, Pierre Théroux, Peter Bogaty, James Nasmith, and Susan Solymoss
Circulation 2001;103:3069-3074
[Abstract]
[Full text]
- Correspondence
Vitamin C and Coronary Microcirculation • Response
- Sebastian J. Padayatty, Mark Levine, Philipp Kaufmann, Paolo G. Camici, Tomaso Gnecchi-Ruscone, Marco di Terlizzi, Thomas F. Luscher, and Klaus P. Schäfers
Circulation 2001;103:e117
[Full text]
- Editorials
In-Hospital Initiation of Lipid-Lowering Therapy for Patients With Coronary Heart Disease : The Time Is Now
- Gregg C. Fonarow and Christie M. Ballantyne
Circulation 2001;103:2768-2770
[Full text]
- Clinician Update
Clinical Trials in Cardiovascular Medicine
- Elliott M. Antman
Circulation 2001;103:e101-104e
[Full text]
- Clinical Investigations and Reports
Comparison of 3 and 6 Months of Oral Anticoagulant Therapy After a First Episode of Proximal Deep Vein Thrombosis or Pulmonary Embolism and Comparison of 6 and 12 Weeks of Therapy After Isolated Calf Deep Vein Thrombosis
- Laurent Pinede, Jacques Ninet, Pierre Duhaut, Sylvie Chabaud, Sylvie Demolombe-Rague, Isabelle Durieu, Patrice Nony, Christian Sanson, and Jean-Pierre Boissel
Circulation 2001;103:2453-2460
[Abstract]
[Full text]
- Clinical Investigations and Reports
Simvastatin Depresses Blood Clotting by Inhibiting Activation of Prothrombin, Factor V, and Factor XIII and by Enhancing Factor Va Inactivation
- Anetta Undas, Kathleen E. Brummel, Jacek Musial, Kenneth G. Mann, and Andrew Szczeklik
Circulation 2001;103:2248-2253
[Abstract]
[Full text]
|
|
